Cervical cancer and H1N1 pandemic vaccine report
Posted by: DrugsNews on: 08 Oct, 2009
Cervical cancer vaccine:
GSK’s Adjuvanted Cervical Cancer Vaccine Receives Favorable Recommendation from FDA Advisory Committee.
The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix, GlaxoSmithKline’s (GSK, Middlesex, UK) candidate cervical cancer vaccine.
H1N1 Influenza Vaccine (Swine flu vaccine):
Baxter Receives EMEA Marketing Authorization [...]
